Performance
5 Days
-11.29%
1 Month
-27.25%
3 Months
-42.11%
6 Months
653.22%
1 Year
318.44%
2 Year
5.77%
Key data
Stock price
$2.75
DAY RANGE
$2.68 - $2.94
52 WEEK RANGE
$0.26 - $5.50
52 WEEK CHANGE
$279.47
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Anne E. Wojcicki
Region: US
Website: 23andme.com
Employees: 770
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry:
Sector:
Region: US
Website: 23andme.com
Employees: 770
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry:
Sector:
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The company was founded in 2006 and is headquartered in South San Francisco, California.
Recent news